Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-03
11:36 am
Sale
13GCue Biopharma, Inc.
CUE
STATE STREET CORP
STT
141,153
0.33%
-1,521,099decrease
(-91.51%)
View
2022-12-02
5:21 pm
Sale
13GCue Biopharma, Inc.
CUE
Nantahala Capital Management, LLC93,297
0.3%
-2,446,403decrease
(-96.33%)
View
2022-11-18
4:04 pm
Purchase
13GCue Biopharma, Inc.
CUE
Slate Path Capital LP2,402,455
5.6%
2,402,455increase
(New Position)
View
2022-07-08
4:57 pm
Sale
13GCue Biopharma, Inc.
CUE
BlackRock Inc.
BLK
831,925
2.4%
-1,458,344decrease
(-63.68%)
View
2022-02-14
4:23 pm
Sale
13GCue Biopharma, Inc.
CUE
Corriente Advisors, LLC0
0%
-1,915,219decrease
(Position Closed)
View
2022-02-14
08:09 am
Purchase
13GCue Biopharma, Inc.
CUE
Nantahala Capital Management, LLC2,539,700
8%
32,928increase
(+1.31%)
View
2022-02-10
1:52 pm
Purchase
13GCue Biopharma, Inc.
CUE
STATE STREET CORP
STT
1,662,252
5.23%
1,662,252increase
(New Position)
View
2022-02-03
4:41 pm
Purchase
13GCue Biopharma, Inc.
CUE
BlackRock Inc.
BLK
2,290,269
7.2%
127,291increase
(+5.88%)
View
2021-02-16
06:28 am
Purchase
13GCue Biopharma, Inc.
CUE
Corriente Advisors, LLC1,915,219
6.33%
1,915,219increase
(New Position)
View
2021-02-12
3:19 pm
Purchase
13GCue Biopharma, Inc.
CUE
Nantahala Capital Management, LLC2,506,772
8.3%
1,101,831increase
(+78.43%)
View
2021-02-12
08:13 am
Sale
13GCue Biopharma, Inc.
CUE
Avoro Capital Advisors LLC452,500
1.5%
-1,417,500decrease
(-75.80%)
View
2021-01-29
09:56 am
Purchase
13GCue Biopharma, Inc.
CUE
BlackRock Inc.
BLK
2,162,978
7.1%
775,309increase
(+55.87%)
View
2020-04-21
3:16 pm
Sale
13DCue Biopharma, Inc.
CUE
MARLETT CHRISTOPHER A1,357,821
4.87%
-98,602decrease
(-6.77%)
View
2020-02-14
12:19 pm
Purchase
13GCue Biopharma, Inc.
CUE
Nantahala Capital Management, LLC1,404,941
6.1%
1,404,941increase
(New Position)
View
2020-02-14
10:24 am
Purchase
13GCue Biopharma, Inc.
CUE
Avoro Capital Advisors LLC1,870,000
8.1%
1,870,000increase
(New Position)
View
2020-02-07
08:45 am
Purchase
13GCue Biopharma, Inc.
CUE
BlackRock Inc.
BLK
1,387,669
6%
1,387,669increase
(New Position)
View
2019-12-17
6:26 pm
Purchase
13DCue Biopharma, Inc.
CUE
MARLETT CHRISTOPHER A1,456,423
6.17%
1,456,423increase
(New Position)
View
2019-02-14
4:20 pm
Sale
13GCue Biopharma, Inc.
CUE
STROME MARK E790,612
3.9%
-358,277decrease
(-31.18%)
View
2018-02-12
8:55 pm
Purchase
13GCue Biopharma, Inc.
CUE
APPEL PETER A1,522,222
7.6%
1,522,222increase
(New Position)
View